Literature DB >> 31030977

Molecular Comprehension of Mcl-1: From Gene Structure to Cancer Therapy.

Viacheslav V Senichkin1, Alena Y Streletskaia1, Boris Zhivotovsky2, Gelina S Kopeina1.   

Abstract

Among cell death regulators, members of the Bcl-2 family are of interest because they are highly conserved across species and represent promising targets for anticancer therapy. This family and its associated proteins include more than 25 members, with either anti- or proapoptotic functions. Although the overall regulation of apoptosis by Bcl-2 family proteins is now well understood, targeted therapy requires careful consideration of individual members of the family and their crosstalk. One of the most studied representatives of the Bcl-2 family is antiapoptotic Mcl-1. After 25 years of investigations, a large amount of data regarding Mcl-1's regulation and functions has been compiled. In this review, we summarize current knowledge about Mcl-1, focusing on molecular aspects relevant to Mcl-1-targeted therapies.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BH3 mimetics; Bcl-2 family; Mcl-1; apoptosis

Mesh:

Substances:

Year:  2019        PMID: 31030977     DOI: 10.1016/j.tcb.2019.03.004

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  27 in total

Review 1.  The roles of microRNAs played in lung diseases via regulating cell apoptosis.

Authors:  Qiaoling Huang; Li Chen; Qinqin Bai; Ting Tong; You Zhou; Zhongyu Li; Chunxue Lu; Shenghua Chen; Lili Chen
Journal:  Mol Cell Biochem       Date:  2021-08-16       Impact factor: 3.396

2.  MCL1 alternative polyadenylation is essential for cell survival and mitochondria morphology.

Authors:  Beatriz C Garcia; Ana Curinha; Isabel Pereira-Castro; Ana Neves-Costa; Eduardo Conde-Sousa; Luís F Moita; Alexandra Moreira
Journal:  Cell Mol Life Sci       Date:  2022-03-01       Impact factor: 9.261

3.  Transient targeting of BIM-dependent adaptive MCL1 preservation enhances tumor response to molecular therapeutics in non-small cell lung cancer.

Authors:  Kaixuan Shi; Haijiao Lu; Zhenfeng Zhang; Yujie Fu; Jie Wu; Shichao Zhou; Pengfei Ma; Kaiyan Ye; Shengzhe Zhang; Hailei Shi; Weiping Shi; Mei-Chun Cai; Xiaojing Zhao; Zhuang Yu; Jian Tang; Guanglei Zhuang
Journal:  Cell Death Differ       Date:  2022-09-28       Impact factor: 12.067

4.  Gga-miR-30c-5p Enhances Apoptosis in Fowl Adenovirus Serotype 4-Infected Leghorn Male Hepatocellular Cells and Facilitates Viral Replication through Myeloid Cell Leukemia-1.

Authors:  Areayi Haiyilati; Linyi Zhou; Jiaxin Li; Wei Li; Li Gao; Hong Cao; Yongqiang Wang; Xiaoqi Li; Shijun J Zheng
Journal:  Viruses       Date:  2022-05-07       Impact factor: 5.818

Review 5.  The E3 Ubiquitin Ligase Fbxo4 Functions as a Tumor Suppressor: Its Biological Importance and Therapeutic Perspectives.

Authors:  Shuo Qie
Journal:  Cancers (Basel)       Date:  2022-04-25       Impact factor: 6.575

Review 6.  Micro RNAs Promoting Growth and Metastasis in Preclinical In Vivo Models of Subcutaneous Melanoma.

Authors:  Ulrich H Weidle; Simon AuslÄnder; Ulrich Brinkmann
Journal:  Cancer Genomics Proteomics       Date:  2020 Nov-Dec       Impact factor: 4.069

7.  A Novel Pharmacological Approach to Enhance the Integrity and Accelerate Restitution of the Intestinal Epithelial Barrier.

Authors:  Xuelei Cao; Lei Sun; Susana Lechuga; Nayden G Naydenov; Alex Feygin; Andrei I Ivanov
Journal:  Inflamm Bowel Dis       Date:  2020-08-20       Impact factor: 5.325

Review 8.  Saga of Mcl-1: regulation from transcription to degradation.

Authors:  Viacheslav V Senichkin; Alena Y Streletskaia; Anna S Gorbunova; Boris Zhivotovsky; Gelina S Kopeina
Journal:  Cell Death Differ       Date:  2020-01-06       Impact factor: 15.828

9.  CRISPR screens identify a novel combination treatment targeting BCL-XL and WNT signaling for KRAS/BRAF-mutated colorectal cancers.

Authors:  Hae Rim Jung; Yumi Oh; Deukchae Na; Seoyeon Min; Jinjoo Kang; Dongjun Jang; Seungjae Shin; Jiwon Kim; Sang Eun Lee; Eui Man Jeong; Joon Yong An; Chang Ohk Sung; Won-Suk Lee; Charles Lee; Sung-Yup Cho
Journal:  Oncogene       Date:  2021-04-12       Impact factor: 9.867

10.  Mcl-1 Interacts with Akt to Promote Lung Cancer Progression.

Authors:  Guo Chen; Dongkyoo Park; Andrew T Magis; Madhusmita Behera; Suresh S Ramalingam; Taofeek K Owonikoko; Gabriel L Sica; Keqiang Ye; Chao Zhang; Zhengjia Chen; Walter J Curran; Xingming Deng
Journal:  Cancer Res       Date:  2019-10-29       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.